EP 3139935 A4 20171115 - THERAPEUTIC PLACENTAL COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE
Title (en)
THERAPEUTIC PLACENTAL COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE
Title (de)
THERAPEUTISCHE PLAZENTALE ZUSAMMENSETZUNGEN, VERFAHREN ZUR HERSTELLUNG UND VERFAHREN ZUR VERWENDUNG
Title (fr)
COMPOSITIONS PLACENTAIRES THÉRAPEUTIQUES, PROCÉDÉS DE FABRICATION ET MÉTHODES D'UTILISATION
Publication
Application
Priority
US 2014037201 W 20140507
Abstract (en)
[origin: WO2015171142A1] This invention provides a therapeutic placental composition comprising placental cells and other placental components derived from placental tissue. A cryopreserved placental composition is also provided. The placental compositions can be used to stimulate and promote angiogenesis, reduce inflammation, and to reduce scar formation, among others. The placental tissue can optionally be an amnion, chorion, a trophoblast-depleted chorion, umbilical cord, Wharton's jelly, placental cotyledon, and/or maternal decidua. The placental composition of the present invention is useful in treating a patient with a tissue injury (e.g., wound or burn) by applying the placental composition to the injury or in close proximity. Placental compositions may also be used to promote or increase regeneration of tissue. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.
IPC 8 full level
A61K 35/50 (2015.01); A61P 17/02 (2006.01)
CPC (source: EP KR)
A61K 35/32 (2013.01 - KR); A61K 35/36 (2013.01 - KR); A61K 35/50 (2013.01 - EP KR); A61K 38/38 (2013.01 - KR); A61K 45/06 (2013.01 - KR); A61P 17/02 (2017.12 - EP); A61P 41/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); A61K 45/06 (2013.01 - EP)
Citation (search report)
- [I] US 2014106447 A1 20140417 - BROWN REBECCAH J C [US], et al
- [Y] WO 2009120996 A1 20091001 - BIOLIFE SOLUTIONS INC [US], et al
- [Y] EP 2702871 A1 20140305 - ANTHROGENESIS CORP [US]
- [I] JI SUK CHOI ET AL: "Full-Thickness Skin Wound Healing Using Human Placenta-Derived Extracellular Matrix Containing Bioactive Molecules", TISSUE ENGINEERING PART A, vol. 19, no. 3-4, 1 February 2013 (2013-02-01), pages 329 - 339, XP055395217, ISSN: 1937-3341, DOI: 10.1089/ten.tea.2011.0738
- See references of WO 2015171142A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2015171142 A1 20151112; AU 2014393402 A1 20161124; CA 2948126 A1 20151112; EP 3139935 A1 20170315; EP 3139935 A4 20171115; JP 2017514876 A 20170608; KR 20160147058 A 20161221; SG 11201609254Y A 20161229
DOCDB simple family (application)
US 2014037201 W 20140507; AU 2014393402 A 20140507; CA 2948126 A 20140507; EP 14891336 A 20140507; JP 2016566997 A 20140507; KR 20167034174 A 20140507; SG 11201609254Y A 20140507